• Lipid Nanoparticle Delivery of ABE8e Edits COL7A1 in DEB Fib

  2026-04-30

  Guri-Lamce et al. demonstrate efficient delivery of the adenine base editor ABE8e via lipid nanoparticles (LNPs) to correct COL7A1 mutations in fibroblasts from dystrophic epidermolysis bullosa (DEB) patients. This study highlights the potential for precise, non-viral gene editing strategies against monogenic skin disorders, with implications for future reporter gene mRNA delivery and optimization.

• Imatinib Hydrochloride: Optimizing Kinase Inhibition Workflo

  2026-04-30

  Imatinib hydrochloride (STI571 hydrochloride) delivers precise, multi-target kinase inhibition for cancer research, enabling rigorous dissection of v-Abl, c-Kit, and PDGFR signaling. Discover actionable workflow enhancements, troubleshooting strategies, and new mechanistic insights rooted in recent advances in kinase-phosphatase interplay.

• Monomethyl Auristatin E (MMAE): Precision Payload, Epigeneti

  2026-04-29

  Discover how Monomethyl auristatin E (MMAE) revolutionizes targeted cancer therapy as a next-generation ADC payload, with new insights into epigenetic plasticity and practical assay design. Explore in-depth analysis and unique perspectives beyond standard protocols.

• Substance P: Advanced Strategies for Bioaerosol Detection Re

  2026-04-29

  Explore how Substance P, a key tachykinin neuropeptide, is revolutionizing bioaerosol detection and hazardous substance classification. This in-depth article provides scientific insights, practical assay parameters, and unique guidance for researchers investigating pain, inflammation, and environmental biosurveillance.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-04-28

  This study demonstrates that activation of PPARγ regulates M1/M2 macrophage polarization and ameliorates dextran sulfate sodium-induced inflammatory bowel disease (IBD) via modulation of the STAT-1/STAT-6 pathway. The findings provide mechanistic insights relevant to immune modulation in IBD and highlight the translational utility of PPARγ agonists in preclinical inflammatory models.

• Dissecting Drug-Induced Cell Fate: In Vitro Evaluation Advan

  2026-04-28

  Schwartz's dissertation advances cancer drug evaluation by distinguishing between proliferative arrest and cell death in in vitro assays, revealing that most anti-cancer agents induce both processes but with varying timing and magnitude. This work clarifies response metrics, informing more nuanced interpretation of tyrosine kinase inhibitor effects in oncology research.

• Olaparib (AZD2281): Applied Workflows for DNA Damage Respons

  2026-04-27

  Olaparib (AZD2281) enables precision-targeted assays in BRCA-deficient and homologous recombination-impaired cancer models. This guide translates the latest research into practical experimental workflows, troubleshooting strategies, and advanced applications for maximizing results in DNA damage response and tumor radiosensitization studies.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-04-27

  This study uncovers CLCC1 as an essential host factor mediating the membrane fusion step required for herpesvirus nuclear egress. The findings refine our understanding of herpesvirus-host interactions and suggest new experimental pathways for targeting viral replication.

• Gentamycin Sulfate: Mechanistic Leverage for Translational R

  2026-04-26

  Explore how Gentamycin Sulfate, a potent aminoglycoside antibiotic, advances translational research on Gram-negative resistance. This thought-leadership article blends mechanistic insight with strategic protocol guidance, competitive benchmarking, and a forward-looking outlook—anchored in peer-reviewed evidence and rigorous workflow recommendations.

• Baicalin: Advancing Neuroplasticity and Cancer Research Fron

  2026-04-25

  This thought-leadership article explores the dual impact of Baicalin, a flavone glycoside from Scutellaria baicalensis, on neuroplasticity and cancer workflows. By dissecting the mechanistic underpinnings—especially KEAP1-NRF2/HO-1 pathway modulation and TGF-β1/p-Smad3 pathway inhibition—we synthesize recent evidence and strategic guidance for translational researchers. Special emphasis is given to Baicalin’s role in restoring visual cortex plasticity in adult amblyopia and enhancing chemotherapeutic sensitivity in oncology models. The piece integrates key findings, protocol parameters, competitive landscape insights, and a forward-looking outlook, demonstrating how Baicalin, as supplied by APExBIO, establishes new benchmarks for reproducibility and innovation beyond standard reagent pages.

• A-1331852: Advancing Senolytic Strategies in Cancer Research

  2026-04-24

  Discover how A-1331852, a potent BCL-XL inhibitor, uniquely enables selective elimination of senescent tumor cells in advanced cancer research. This article explores deeper mechanistic insights, translational applications, and protocol guidance beyond standard apoptosis assays.

• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy & C

  2026-04-24

  RapaLink-1 redefines experimental control of the mTOR pathway, enabling reproducible induction of embryonic dormancy and robust inhibition of tumor growth even in resistant models. Its bivalent mechanism delivers unmatched potency for both oncology and developmental biology, setting new standards for protocol-driven research.

• Scenario-Driven Solutions with Entinostat (MS-275, SNDX-275)

  2026-04-23

  This authoritative guide addresses real-world challenges in cancer cell viability and proliferation assays using Entinostat (MS-275, SNDX-275), SKU A8171. Through scenario-based Q&A, we translate evidence-backed protocols and data interpretation strategies into practical laboratory actions, demonstrating the value of APExBIO’s formulation for reproducibility and workflow optimization.

• Rapamycin-Induced Autophagy Regulates Lipid Metabolism in Sa

  2026-04-23

  This study demonstrates that autophagy, induced by rapamycin, enhances lipid droplet breakdown and mitigates lipotoxicity in Atlantic salmon cells. By integrating lipidomics and proteomics, the authors establish a conserved autophagy pathway in fish cells, with implications for aquaculture health and metabolic research.

• Everolimus (RAD001): Quantitative Drug Response Insights Bey

  2026-04-22

  Explore how Everolimus (RAD001) enables advanced, quantitative analysis of cancer cell responses beyond standard viability assays. Discover unique methodological strategies, practical assay guidance, and the latest research insights for optimizing mTOR pathway inhibition.

16426 records 1/1096 page Next 12345 下5页 Last page